Kyprolis: FDA Advisers Back Blood Cancer Drug For Some Patients
Panel members said the drug gave people another option to try to beat back the disease. A panel of outside advisers to the
kyprolis fda advisers blood cancer drug patients panel member say drug give people option try beat disease panel o USA de adviser